NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) is a clinical-stage biopharmaceutical company focused on creating novel therapeutics that use molecules to treat medical conditions with no approved cure. The Company’s lead product candidate is ZYESAMI™ (AVIPTADIL®) ZYESAMI™ (Aviptadil acetate), a synthetic Vasoactive Intestinal Peptide (VIP), which has...
Insider selling cannot be the sole indicator for investing in a stock, but it would be wise to make a note of the buying and selling activities to gauge a company’s prospects or the lack thereof. While insiders buying or selling the Company’s stock could...
Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) develops Anticalin-based drugs for treatment of conditions related to immuno-oncology and respiratory diseases such as Asthma and Anaemia. Anticalin proteins are engineered versions of lipocalins that are human proteins having the ability to bind, store and transport molecules, which the Company has...
Ardelyx, Inc. (NASDAQ: ARDX) lead candidate Tenapanor, is a targeted, first-in-class, oral, small molecule intended for the control of serum phosphorus in adult patients with chronic kidney disease (CKD) on dialysis. The drug has the potential to become a foundational therapy for hyperphosphatemia and enable...
Clinical-Stage companies offer an exciting investment opportunity with massive upside potential. Most of these companies bring new and highly differentiated approaches, advanced scientific knowledge and a zeal for innovation to the table. Our biotech picks this week are making strides in fields such as immune-oncology, hematologic...
Insider selling or buying cannot be the sole indicator for investing in a stock, but it would be wise to make a note of the buying and selling activities to gauge a company’s prospects or the lack thereof. While insiders buying or selling the Company’s...
Beyond Air, Inc. (NASDAQ: XAIR) formerly known as AIT Therapeutics, Inc, is a clinical-stage biopharmaceutical and medical device company that uses a proprietary technology to produce nitric oxide from ambient air through its LungFit System. The device enables the administration of ultra-high nitric oxide concentrations...
Insider selling cannot be the sole indicator for investing in a stock, but it would be wise to make a note of the buying and selling activities to gauge a company’s prospects or the lack thereof. While insiders buying or selling the Company’s stock could...
Clinical-Stage companies offer an exciting investment opportunity with massive upside potential. Most of these companies bring new and highly differentiated approaches, advanced scientific knowledge and a zeal for innovation to the table. However, clinical trials are fraught with risk and uncertainty. Even the slightest setback can...
Gritstone Bio, Inc. (NASDAQ: GRTS), formerly known as Gritstone Oncology, is a clinical-stage biotechnology company developing targeted immunotherapies for a range of diseases in the cancer and infectious disease space. The Company’s approach is based on leveraging the inherent abilities of the immune system to...
